Sign in

CIK 0001773751

  • Large accelerated filer

Hims & Hers Health, Inc.

Sign in to watch
Ticker
HIMS
Exchange
NYSE
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 415-851-0195
Business address
2269 CHESTNUT ST, #523, SAN FRANCISCO, CA, 94123
Former names
Oaktree Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,483,933
in 10 filings, $2.5M under 10b5-1 plans

Net −$2,483,933. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-08-18 Dudum Andrew Chief Executive Officer Sale 10b5-1 −47,534 $45.05 $2.1M 142,592
2025-08-18 Dudum Andrew Chief Executive Officer Sale 10b5-1 −2,792 $44.97 $126K 89,521
2025-08-18 Dudum Andrew Chief Executive Officer Exercise or conversion 10b5-1 +17,001 $2.43 $41K 106,522
2025-08-18 Dudum Andrew Chief Executive Officer Sale 10b5-1 −17,001 $45.14 $767K 89,521
2025-08-18 Dudum Andrew Chief Executive Officer Exercise or conversion 10b5-1 +108,334 $2.43 $263K 197,855
2025-08-18 Dudum Andrew Chief Executive Officer Sale 10b5-1 −41,667 $45.11 $1.9M 156,188
2025-08-18 Dudum Andrew Chief Executive Officer Sale 10b5-1 −50,000 $45.04 $2.3M 106,188
2025-08-18 Dudum Andrew Chief Executive Officer Sale 10b5-1 −16,667 $44.92 $749K 89,521
2025-08-18 Dudum Andrew Chief Executive Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −17,001 51,007
2025-08-18 Dudum Andrew Chief Executive Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −108,334 648,063
2025-08-13 Okupe Oluyemi Chief Financial Officer Exercise or conversion 10b5-1 +11,581 $5.01 $58K 65,665
2025-08-13 Okupe Oluyemi Chief Financial Officer Sale 10b5-1 −11,581 $48.05 $556K 116,806
2025-08-13 Okupe Oluyemi Chief Financial Officer Exercise or conversion · Stock Option (right to buy) 10b5-1 −11,581 361,365
2025-08-11 Boughton Soleil Chief Legal Officer Sale 10b5-1 −2,572 $51.64 $133K 153,021
2025-08-07 Dudum Andrew Chief Executive Officer Sale −660,000 $50.58 $33.4M 2,214,769
2025-08-06 WELLS DAVID B Director Grant or award · Restricted Stock Unit +3,656 3,656
2025-08-06 Payne Christopher D Director Grant or award · Restricted Stock Unit +3,656 3,656
2025-08-06 Perez Garcia Andrea G Director Grant or award · Restricted Stock Unit +3,656 3,656
2025-08-06 Cosgrove Delos M. Director Grant or award · Restricted Stock Unit +3,656 3,656
2025-08-06 Autor Deborah M. Director Grant or award · Restricted Stock Unit +3,656 3,656

Page 26 of 37 · 739 trades